The Molecule and the Machine
In 2024, a single molecule called Melasyl — engineered in one of L'Oréal's twenty-one research centers and capable of intercepting the biochemical pathway that produces dark spots on human skin before pigmentation even forms — was embedded into a La Roche-Posay serum that became one of the year's best-selling dermatological products globally. The molecule had been identified by artificial intelligence scanning hundreds of compounds per year against L'Oréal's proprietary database of sixteen terabytes of beauty data, a process that once consumed months of laboratory time for a single candidate. In isolation, it is a skincare ingredient. In context, it is the output of a 116-year-old machine — part chemistry laboratory, part brand portfolio engine, part acquisition flywheel, part cultural antenna — that has generated €43.5 billion in annual revenue, a market capitalization exceeding €200 billion, and a position so dominant that its research and innovation budget alone exceeds those of its next three competitors combined.
The machine was built by a chemist. It was scaled by executives who understood that beauty is not one market but an infinity of markets — segmented by price point, by skin tone, by geography, by aspiration, by the vanity that is also a form of dignity. And it has been sustained by a family that, through multiple generations and an extraordinary succession of scandals, has maintained controlling governance over the entity for over a century. L'Oréal is not merely the world's largest beauty company. It is among the most quietly extraordinary compounding machines in the history of European capitalism — a business that has outperformed the global beauty market's estimated 4.5% annual growth rate in almost every year of the last two decades, that has nearly doubled its revenue since 2014, and that has done so while operating in a category most investors once dismissed as too fragmented, too trend-driven, and too dependent on the whims of consumer taste to generate durable competitive advantage.
They were wrong.
By the Numbers
L'Oréal at a Glance
€43.5BNet revenue (FY2024)
37Global brands across four divisions
€1.3BAnnual R&D investment
4,000+Researchers across 21 global centers
3,636New formulas launched in 2024
150+Countries where products are sold
~€200B+Market capitalization
116Years in continuous operation
The Chemist Who Sold to Hairdressers
Eugène Paul Louis Schueller was born in 1881 to Parisian pastry chefs whose modest business and ill-fated investment in the Panama Canal left the family financially broken before the boy reached adolescence. He worked to support them, saved enough to enroll in the Institute of Applied Chemistry, graduated first in his class in 1904, and took a position as a laboratory assistant at the Sorbonne — respectable, secure, modestly compensated. The trajectory of a university researcher. But Schueller had a restless, commercially obsessive mind, and what it fixed upon was a prosaic problem: in the early 1900s, hair dye was dangerous, unreliable, and frequently disfiguring. Burned scalps, unpredictable colors, chemical reactions that bore no resemblance to the shade promised on the label.
In his tiny Paris apartment, mixing formulas and testing on whatever organic material was available, Schueller developed the first safe synthetic hair dye. He called it Oréale. And then — this is the crucial detail, the thing that separates a chemist from a founder — he did not wait for the hairdressers to come to him. He went to them. Personally. Salon by salon across Paris, demonstrating the product, explaining the chemistry, building relationships with the professionals who would serve as both his distribution channel and his credibility engine. In 1909, he incorporated the company as Société Française de Teintures Inoffensives pour Cheveux — the French Society for Harmless Hair Dyes. The name tells you everything about the value proposition: not glamour, not aspiration, but safety. Science as the foundation of trust.
What Schueller built in those early decades was not just a product line but a template — one that L'Oréal would repeat, with variations, for the next century. Innovate in the laboratory. Sell through professionals who confer authority. Expand the product portfolio laterally into adjacent categories (shampoos, styling treatments, and in the 1930s, Ambre Solaire, one of the first commercial sunscreens, launched just as the paid vacation — which Schueller himself politically opposed — sent millions of French workers to the beach for the first time). And above all, market with a sophistication that exceeded anything the industry had seen. Before "branding" was a discipline, Schueller crafted advertising that connected personal care to identity and confidence. He understood, instinctively, that beauty products are purchased not for their chemical composition but for the story the buyer tells herself about who she is becoming.
The template has endured. The founder's personal history is more complicated.
The Shadow in the Formula
Schueller's political entanglements constitute one of the more disturbing chapters in the history of any major consumer brand. He was a member of La Cagoule, a violent far-right, anti-communist organization in 1930s France, hosting meetings at L'Oréal's own headquarters and providing financial support. During World War II, his relationships with the Nazi-aligned Vichy government — and his documented connection to SS officer Helmut Knochen, responsible for the deportation of French Jews and the execution of Resistance members — helped L'Oréal's sales quadruple during the occupation. A 1947 French investigation listed "E. Schueller. Businessman" among Knochen's identified agents.
After the war, Schueller claimed to have secretly supported the Resistance. Future French president François Mitterrand and Schueller's own son-in-law, André Bettencourt — himself a former contributor to a collaborationist publication — helped rehabilitate his reputation. Schueller hired former La Cagoule members at L'Oréal. He died in 1957, wealthy and largely unpunished, leaving behind a business that was already the dominant force in French beauty and a legacy that Ruth Brandon would later excavate in
Ugly Beauty: Helena Rubinstein, L'Oréal, and the Blemished History of Looking Good, a book that traces the intersection of the beauty industry with twentieth-century politics and the specific moral rot that allowed a cosmetics fortune to be built on collaboration.
The company has never fully reconciled with this history. It exists as a kind of geological layer — visible if you dig, invisible in the daily experience of purchasing a Lancôme serum or a Garnier shampoo. What it reveals, beyond the specific moral horror, is something about the nature of consumer brands: their ability to be simultaneously intimate — touching your skin, shaping your reflection — and structurally indifferent to the circumstances of their own creation. L'Oréal's products were no less effective because their founder funded fascists. The molecule doesn't care about the man who built the laboratory.
The Inheritance and the Architecture
Schueller's sole heir was his daughter Liliane, who had lost her mother at five and grown up essentially alone with a father whose brilliance was inseparable from his extremism. She married André Bettencourt, a politician and former Vichy-era journalist, and inherited the L'Oréal fortune upon Schueller's death. For decades, Liliane Bettencourt occupied a position of extraordinary quiet power — the largest individual shareholder in the world's largest beauty company, her net worth eventually estimated at approximately €33 billion, making her the richest woman on the planet.
Her story would become, in its final chapters, a French national saga. In 2007, after André Bettencourt's death, their daughter Françoise Bettencourt Meyers sued Liliane's flamboyant companion François-Marie Banier, a photographer and society figure who had received nearly €1 billion in gifts — paintings, life insurance policies, a salary from L'Oréal itself. The investigation expanded into the "Bettencourt affair," threatening to engulf President Nicolas Sarkozy, who was alleged to have received illegal campaign financing from the elderly heiress. Sarkozy's charges were eventually dropped for lack of evidence; Banier was convicted of exploitation in 2015, sentenced to prison, and ordered to pay €158 million in damages. Liliane Bettencourt, declared to have dementia, was placed under her family's guardianship in 2011. She died in September 2017 at ninety-four.
The affair was tawdry and riveting — staff whispering about Banier urinating in the flowerbeds, lying on Bettencourt's bed with his shoes on — but beneath the tabloid surface lay a more consequential story about governance. The Bettencourt family's controlling stake in L'Oréal, structured through the holding company Téthys, has functioned as a cornerstone of stability. It insulates the company from activist shareholders, hostile takeovers, and the quarterly myopia that distorts so many publicly traded consumer businesses. Françoise Bettencourt Meyers, who stepped down from the board in early 2025 and passed her seat to her son Jean-Victor Meyers, represents the third generation of family oversight. The Bettencourt-Meyers family holds approximately 35% of L'Oréal's shares and roughly 46% of voting rights. Nestlé, the Swiss food giant, was the other major shareholder for decades — a relationship dating to a 1974 agreement between Liliane Bettencourt and Nestlé to prevent a hostile takeover — before gradually divesting its stake, selling its final 23.3% holding in 2023, ending a nearly fifty-year partnership.
The family structure has enabled L'Oréal to operate with a time horizon that most public companies can only envy. It can invest €1.3 billion annually in R&D — roughly 3% of sales, far exceeding industry norms — without facing pressure to redirect those funds toward buybacks. It can pursue acquisitions that take years to integrate. It can lose money in China for a decade before the market matures. The Bettencourt family is not operationally involved, but their presence — patient, long-term, content with capital appreciation rather than demanding dividends — shapes the company's strategic metabolism.
The Universalization Doctrine
If Schueller invented L'Oréal's scientific DNA, the men who succeeded him — François Dalle, Charles Zviak, Lindsay Owen-Jones, and Jean-Paul Agon — built its global architecture. The most consequential of these was arguably Owen-Jones, a Welsh-born executive who joined L'Oréal in 1969 and served as CEO from 1988 to 2006, transforming the company from a primarily European business into a genuinely global one. Under his leadership, L'Oréal acquired Maybelline in 1996, gaining deep penetration into the American mass market. He added Kiehl's in 2000 for an estimated $180 million — a beloved New York pharmacy brand founded in 1851 that would become a template for how L'Oréal could acquire cult brands and scale them globally without destroying the artisanal mystique that made them valuable.
Jean-Paul Agon, who succeeded Owen-Jones, joined L'Oréal straight from HEC Paris in 1978 and never left — a career lifer whose experience running subsidiaries in Greece, Germany, and across Asia during the 1997 financial crisis gave him an unusually granular understanding of how beauty markets develop in different economic and cultural contexts. He became CEO in 2006 and chairman in 2011. Agon's signature concept was "universalization" — the idea that beauty is a universal human aspiration but that its expression is infinitely local. The company's job was not to export French beauty standards but to understand and serve the specific desires of consumers in Johannesburg, Shanghai, São Paulo, and Jakarta, adapting formulations, shades, textures, and marketing to each context while leveraging a global R&D infrastructure and brand portfolio that no local competitor could match.
This was not merely rhetoric. Agon opened factories in Mexico, Egypt, and Indonesia. He created regional research hubs that studied local hair types, skin tones, and climate conditions. He invested in brands — like the Indian Ayurvedic line — that had no relevance in Paris but enormous potential in South Asia. The result was a company that could credibly claim to serve every price point, every skin type, every distribution channel, and every major geography on Earth.
Who gained shares? None of our big competitors. We lost to the local players.
The candor of that 2016 admission — delivered at a conference, with analysts listening — captures something essential about L'Oréal's culture. The company is not complacent. It watches the periphery. When the threat materialized in the form of digital-native brands and social media-powered insurgents, L'Oréal's response was not to dismiss them but to study, acquire, and in many cases, absorb them.
The Acquisition Machine
The story of L'Oréal's competitive dominance cannot be told without understanding its acquisition strategy — arguably the most disciplined and consistently successful brand-acquisition program in consumer goods history. The company operates as a kind of solar system: the gravitational center is the R&D infrastructure, the global distribution network, and the marketing engine, and around it orbit thirty-seven brands, each acquired or developed to fill a specific strategic position in the portfolio.
Key acquisitions across L'Oréal's four divisions
1964Acquires Lancôme, entering luxury beauty. Now estimated at ~€4.5B in annual sales.
1996Acquires Maybelline, establishing mass-market dominance in the U.S.
2000Acquires Kiehl's for ~$180M. A cult New York pharmacy brand scaled globally.
2006Acquires The Body Shop for ~€940M (sold to Natura & Co. in 2017).
2014Acquires NYX Professional Makeup, a social-media-native brand.
2016Acquires IT Cosmetics for $1.2B — L'Oréal's largest acquisition at the time.
2017Acquires CeraVe, Acne
Free, and Ambi from Valeant for ~$1.3B.
The CeraVe acquisition, in particular, deserves scrutiny. In 2017, L'Oréal purchased the dermatologist-developed skincare brand from Valeant Pharmaceuticals as part of a roughly $1.3 billion bundle that also included Acne Free and Ambi. CeraVe was a sleeper — a no-frills, pharmacy-distributed brand beloved by dermatologists but largely invisible to mainstream consumers. L'Oréal placed it within its Dermatological Beauty division alongside La Roche-Posay and SkinCeuticals and proceeded to deploy its digital marketing machine. When TikTok's skincare community discovered CeraVe — driven by dermatologist influencers recommending its ceramide-based formulas — the brand exploded. By 2023, CeraVe had become one of the fastest-growing skincare brands globally. The acquisition price looks, in retrospect, like theft.
The IT Cosmetics deal tells a different but equally instructive story.
Jamie Kern Lima, a former Denny's waitress and television news anchor who struggled with rosacea, founded IT Cosmetics in 2008 after being rejected by every major retailer. When L'Oréal acquired the brand for $1.2 billion in 2016, it was the largest acquisition in L'Oréal USA history and the first time L'Oréal had acquired a brand founded by a woman. Kern Lima's story — the outsider who built a billion-dollar brand by solving her own problem — rhymes with Schueller's origin, and L'Oréal's willingness to pay a premium for that kind of founder-driven authenticity reflects a deeper understanding: in beauty, the story is the product.
Whenever we see a small company with a good idea, we're on fire.
Since 2017, L'Oréal's acquisition spending has increased roughly tenfold, from approximately €100 million to approximately €1 billion per year, excluding the massive Kering Beauté transaction. The company also operates BOLD — Bold Opportunities for L'Oréal Development — a venture fund that takes minority stakes in emerging brands and technologies, functioning as a scouting mechanism for future acquisitions. The logic is simple and relentless: the beauty market is fragmenting, new brands emerge constantly from social media, and L'Oréal's competitive advantage lies not in preventing their emergence but in identifying the winners early and folding them into the machine.
Because She Was Worth It
In 1972, a junior copywriter named Ilon Specht sat in the offices of McCann Erickson, the advertising agency that held the L'Oréal account, and wrote four words that would become one of the longest-running advertising slogans in history: "Because I'm worth it." She was twenty-three years old, working in an industry dominated by men who crafted campaigns that spoke to women as objects to be assessed rather than agents of their own desire. The prevailing language of beauty advertising addressed the male gaze — make him notice you, look beautiful for him. Specht's line shifted the subject. The woman was worth it. Not for anyone else. For herself.
The slogan — later adapted to "Because you're worth it" and then "Because we're worth it" — has survived for more than fifty years, outlasting every campaign cycle, every creative director, every shift in media. As Specht's stepdaughter would later describe it: "It's a four-word feminist manifesto." Oscar-winning director Ben Proudfoot filmed a documentary short about Specht, The Final Copy of Ilon Specht, released after her death from cancer in 2024 at the age of eighty-one. Proudfoot noted that had Specht written the line today, she would have had a far more celebrated career — but because it was 1972, she never received the opportunities her talent merited. She probably had twenty more taglines in her, campaigns as compelling or more so, that never got made.
The slogan's longevity is not accidental. It expresses something real about L'Oréal's positioning — the claim that beauty products are not frivolous expenditure but a form of self-investment, that spending more on a superior product is an act of self-respect. This is the architecture of L'Oréal's pricing power: products positioned as investments in yourself, justified by the science behind them, endorsed by professionals (dermatologists, hairdressers, makeup artists), and backed by an R&D operation that can credibly claim to deliver innovation rather than merely repackaging. The slogan is not just marketing. It is the company's unit economic argument, stated in the language of aspiration.
The Four Rooms of the House
L'Oréal's portfolio is organized into four divisions, each targeting a distinct consumer, channel, and price point — a structure the company describes as its "multi-divisional, multi-brand, multi-channel" model. Understanding this architecture is essential to understanding why L'Oréal is so difficult to displace.
L'Oréal Luxe encompasses prestige brands — Lancôme, Yves Saint Laurent Beauté, Giorgio Armani Beauty, Valentino Beauty, Kiehl's, and others — distributed primarily through department stores, Sephora, duty-free, and the brands' own boutiques. Lancôme alone is estimated to generate approximately €4.5 billion in annual revenue, making it the world's leading luxury beauty brand. Over the past decade, its sales have multiplied roughly 2.5 times. This division became the world's largest luxury beauty player roughly two years ago, a fact CEO Nicolas Hieronimus — who previously ran the Luxe division before ascending to the top job — cites with undisguised satisfaction.
Consumer Products houses the mass-market workhorses — L'Oréal Paris, Garnier, Maybelline, NYX Professional Makeup — sold through supermarkets, drugstores, and mass-market retailers. These are the volume brands, the ones generating billions of units sold annually at accessible price points. L'Oréal Paris itself, under the leadership of Delphine Viguier-Hovasse (recently elevated to the newly created role of Chief Innovation and Prospective Officer), became the world's leading beauty brand — a remarkable fact when you consider the fragmentation of the mass market.
Dermatological Beauty — the division housing La Roche-Posay, CeraVe, SkinCeuticals, and Vichy — has been the company's fastest-growing segment in recent years, riding the global consumer shift toward "skinification" and dermatologist-recommended products. The genius of this division is its distribution channel: pharmacies and dermatology practices, which confer an authority that no amount of influencer marketing can replicate.
Professional Products serves hairdressers and salon professionals — the original channel that Schueller himself pioneered in 1909. Brands like Kérastase and Redken are sold through salons, making hairdressers both the customer and the endorsement mechanism.
The four divisions are not merely organizational — they are a strategic moat. A competitor can challenge L'Oréal in one division, or one category, or one geography. But to challenge it across all four divisions, all major categories (skincare, makeup, haircare, fragrance), and all major geographies simultaneously requires a scale of investment that no other beauty company possesses and no new entrant can plausibly assemble.
Estée Lauder, L'Oréal's closest publicly traded competitor, has roughly $15 billion in revenue and competes primarily in prestige. Procter & Gamble competes in mass but lacks prestige and dermatological brands. Unilever, Shiseido, LVMH — each has a slice. None has the whole house.
The Science of Surfaces
L'Oréal spends more on research and innovation than any other beauty company. The €1.3 billion annual budget funds more than 4,000 researchers across twenty-one centers globally — from Aulnay-sous-Bois outside Paris to Tokyo, Shanghai, Johannesburg, and Clark, New Jersey. In 2023 alone, the company filed 610 patents, conducted 17,000 product evaluations, and produced approximately 35,000 formulas. In 2024, it launched 3,636 new formulas. These are not cosmetic reformulations — many represent genuine scientific advances in understanding skin biology, hair chemistry, and the interaction between environmental factors and human integument.
Forty years ago, L'Oréal pioneered the development of reconstructed human skin — laboratory-grown epidermis that could be used for product testing, eliminating the need for animal testing long before regulatory or consumer pressure demanded it. This was not corporate social responsibility as a marketing exercise. It was a scientific capability that accelerated product development, reduced liability, and gave L'Oréal a testing infrastructure that competitors would take decades to replicate.
We have always considered our business model was to bring to market products that are state of the art, charge a bit more, and globalize.
The AI transformation of L'Oréal's research is not a press release — it is a genuine operational shift. The company's sixteen terabytes of proprietary beauty data — accumulated over a century of studying hair, skin, and color — now serve as training data for machine learning models that scan new molecules, predict efficacy, and accelerate formulation. "Our labs are powered by AI," Hieronimus told Fortune in 2025. "It is an advantage." The commercial result is faster reformulation and the ability to develop entirely new products like the Melasyl-containing Mela B3 serum. New products represent 10–15% of L'Oréal's global business each year — a staggering renewal rate for a company of its scale.
Downstream, L'Oréal has deployed AI consumer-facing tools: the L'Oréal Paris Beauty Genius, an AI agent launched in 2024 that advises consumers on purchases, has already attracted more than 100,000 users. The data suggest that consumers who receive personalized recommendations purchase up to eight times the amount of L'Oréal products as an average consumer — a retention and upselling metric that justifies the technology investment many times over. Since 2017, L'Oréal has won eighteen innovation awards at CES, the world's largest consumer technology trade show — a remarkable fact for a cosmetics company, and a signal of how seriously the industry should take its technology ambitions.
Barbara Lavernos, the chemical engineer who was elevated to deputy CEO in 2021 alongside Hieronimus's ascent — the first time L'Oréal had structured its senior leadership to place a technologist at the very top of the operational hierarchy — oversees both R&I and the company's eight-thousand-plus technology and data specialists. L'Oréal invests more than €1 billion annually in IT and technology on top of the €1.3 billion in R&I. "The world has changed radically," Lavernos told WWD. "The next ten to fifteen years are undoubtedly years of huge discoveries."
The Disruption That Wasn't
A decade ago, the disruption narrative seemed inevitable. Digital-native brands — Glossier, e.l.f. Beauty, Kylie Cosmetics, Fenty Beauty, the surging Korean beauty wave — had a critical structural advantage: they were built for social media and e-commerce, while L'Oréal's model was anchored in traditional media advertising and brick-and-mortar retail. The playbook was familiar. Incumbents would be disintermediated. The conglomerate model would fragment. This was supposed to be L'Oréal's Kodak moment.
It didn't happen.
Instead, L'Oréal did three things simultaneously. First, it acquired digital-native brands that understood the new channels — NYX Professional Makeup in 2014, IT Cosmetics in 2016 — and used them as learning organisms, reverse-engineering their social media and DTC capabilities and deploying those capabilities across the broader portfolio. Second, it invested massively in its own digital transformation, building e-commerce capabilities, social media marketing teams, and data analytics infrastructure. Third, it accelerated its innovation cycle, launching products at a pace that made it difficult for smaller competitors to maintain their relevance advantage — if L'Oréal is launching 3,636 formulas a year, the indie brand launching twenty has a narrower window of differentiation.
The result: L'Oréal has "consistently outperformed the €290 billion global beauty market, which itself continues to grow at an estimated +4.5%," as Fortune reported in 2025. Its revenue has nearly doubled since 2014. Estée Lauder, by contrast, has stumbled — losing market share in the U.S. to L'Oréal's CeraVe and SkinCeuticals, underinvesting in advertising, and misreading the China reopening, leading to three consecutive quarters of reduced annual guidance. The gap has widened. L'Oréal's annual revenue of approximately €43.5 billion dwarfs Estée Lauder's roughly $15 billion. The disruption narrative didn't account for the possibility that the incumbent might be the most adaptive organism in the ecosystem.
The Sixth CEO and the Kering Bet
Nicolas Hieronimus became CEO of L'Oréal in May 2021 — only the sixth person to hold the role in 116 years, a succession cadence that speaks to the company's institutional patience. He joined L'Oréal in 1987, spent three decades rising through the ranks, and ran the Luxe division before taking the top job. His leadership style is characterized by an unusual combination of expansiveness and precision — a CEO who jokes about selling beauty products to Martians and simultaneously executes a €4 billion acquisition of Kering's beauty portfolio with the strategic logic of a chess grandmaster.
The Kering Beauté deal, agreed in 2024, is transformative. It brings the beauty licenses for Bottega Veneta, Balenciaga, Alexander McQueen, and other Kering luxury houses under L'Oréal's roof, dramatically strengthening the company's fragrance portfolio and deepening its relationship with the luxury fashion ecosystem. Hieronimus has described acquisitions as a way "to learn and to grow" — an admission that even a company of L'Oréal's scale cannot generate all its insights internally.
I don't believe in traces. Traces, like footprints in the sand, can vanish once a wave passes. But I like the concept of movement — of beauty that moves the world.
The company he leads is, at its core, a paradox machine: a 116-year-old institution that behaves like a startup when threatened, a scientific laboratory that generates aspirational emotions, a French family business that operates in 150 countries, a consumer goods company that wins awards at CES. It has survived Nazi collaboration, family feuds that became national political scandals, the digital disruption of its entire distribution model, a pandemic that put masks on every face and crushed makeup sales — and emerged, each time, larger.
An Image That Resolves
In July 2007, a French appeals court found L'Oréal's Garnier division guilty of racial discrimination — the first time a major French company had been convicted of systematic racial bias in hiring. The case centered on a 2000 recruitment campaign for Fructis Style promoters in which an internal fax stipulated that candidates should be "BBR" — bleu, blanc, rouge, the colors of the French flag, a far-right code meaning "white." Of the women recruited for the campaign, less than 4% were of non-European origin, compared to the 40% that would be expected in a normal sample.
Garnier and the recruitment agency were each fined €30,000. The amount was trivial for a company of L'Oréal's scale. The conviction was not.
Today, L'Oréal's global marketing celebrates diversity as a core brand value. Its Stand Up program against street harassment has trained nearly three million people worldwide. Its Lancôme Le Défilé during Paris Fashion Week is a celebration of inclusive beauty. The company's shade ranges, ingredient libraries, and regional research centers are designed to serve every skin tone, every hair texture, every cultural context. The gap between the 2000 fax and the 2025 brand proposition is real — the company has genuinely transformed. But the gap also illustrates something about the nature of large institutions: they contain multitudes, some of them in direct contradiction, and the distance between what a corporation says and what it does is always, at any given moment, a question worth asking.
In 2024, L'Oréal reported that it had reduced its packaging intensity by 11% since 2019, and that the number of its products available in refillable or reusable containers had grown seventeen-fold over the same period. At €43.5 billion in annual sales, even modest percentage improvements in packaging represent millions of fewer plastic containers entering the waste stream. The company invested over €1.3 billion in research. It launched 3,636 formulas. Its AI systems scanned hundreds of new molecules. And somewhere in a laboratory, a machine learning model trained on sixteen terabytes of proprietary data identified a compound that might, one day, become the next Melasyl — a molecule that no one has seen yet, for a product that doesn't exist, to be sold under a brand that might not have been acquired, in a market that has not yet emerged.
The chemist's kitchen experiment, scaled to the edges of the known world. Still running.
